info@strategicmarketresearch.com
92, An Guha Lane, Arya Samaj Gali, Sambalpur, Odisha -768001
Indian Flag  IN: +91-826-083-6500
Home » Healthcare

Healthcare

Corneal Cross-Linking Devices Market By Product Type (UVA Irradiation Systems, Riboflavin and Photoenhancer Products, Oxygen-Delivery Systems, Accessories and Single-Use Consumables, Integrated Corneal Cross-Linking Platforms); By Procedure Type (Epithelium-Off Corneal Cross-Linking, Epithelium-On Corneal Cross-Linking, Customized or Accelerated Corneal Cross-Linking); By Application (Keratoconus, Post-Refractive Corneal Ectasia, Pellucid Marginal Degeneration, Infectious Keratitis, Other Corneal Disorders); By End User (Ophthalmology and Corneal Specialty Clinics, Hospitals, Ambulatory Surgery Centers, Academic and Research Institutions); By Geography, Segment Revenue Estimation, Forecast, 2026–2032

Corneal Cross-Linking Devices Market: Epi-On Adoption Reshapes the Commercial Pathway for Keratoconus Care

The Global Corneal Cross-Linking Devices Market was valued at USD 285 million in 2025 and is projected to reach USD 501 million by 2032, expanding at a CAGR of 8... Read More

Published Date: JUL-2026 | No Of Pages:166 | $ 4485

Innate Immunity Modulators Market By Modulator Type (Innate Immunostimulants and Agonists, Innate Immunosuppressants and Inhibitors, Engineered Cytokines and Other Biological Response Modifiers); By Target Pathway (Toll-Like Receptors, cGAS–STING, NLRP3 and Other NOD-Like Receptors, RIG-I-Like Receptors, TREM1 and Other Myeloid Pathways); By Application (Oncology, Autoimmune and Inflammatory Disorders, Infectious Diseases, Vaccine Adjuvants, Neurological Disorders, Other Applications); By Route of Administration (Topical, Intravesical, Intratumoral, Injectable, Oral); By Geography, Segment Revenue Estimation, Forecast, 2026–2032

Innate Immunity Modulators Market — Approved Therapies, Pipeline Evolution and Regional Commercial Outlook

The Global Innate Immunity Modulators Market was valued at USD 5.20 billion in 2025 and is projected to reach USD 9.82 billion by 2032, expanding at a CAGR... Read More

Published Date: JUL-2026 | No Of Pages:190 | $ 4485

Batten Disease Treatment Market By Treatment Type (Enzyme Replacement Therapy, Antiseizure Medications, Symptomatic and Supportive Therapy, Gene Therapy and Other Investigational Treatments), By Disease Type (CLN1 Disease, CLN2 Disease, CLN3 Disease, CLN5 Disease, CLN6 Disease, CLN7 Disease, CLN8 Disease, Other Neuronal Ceroid Lipofuscinosis Types), By Route of Administration (Intracerebroventricular, Oral, Intravenous, Other Routes), By Distribution Channel (Hospital Pharmacies, Specialty Pharmacies, Retail Pharmacies, Other Distribution Channels), By Geography, Segment Revenue Estimation, Forecast, 2026–2032

Batten Disease Treatment Market: A High-Value CLN2 Therapy Anchors a Wider Supportive-Care Market

The Global Batten Disease Treatment Market was valued at USD 0.21 billion in 2025 and is projected to reach USD 0.55 billion by 2032, expanding at a CAGR of 14.7% during ... Read More

Published Date: JUL-2026 | No Of Pages:160 | $ 4485

Skin Biopsy Devices Market By Product Type (Biopsy Punches, Shave-Biopsy Blades, Dermal Curettes, Scalpels and Excisional Instruments, Scissors and Snip-Biopsy Instruments, Biopsy Kits, Microbiopsy and Emerging Sampling Devices); By Usage (Disposable Devices, Reusable Instruments); By Application (Skin-Cancer Diagnosis, Atypical and Benign Lesion Assessment, Inflammatory Skin Disorders, Infectious Skin Diseases, Alopecia and Scalp Disorders, Neurological Biomarker Testing, Clinical Research and Molecular Analysis); By End User (Dermatology Clinics, Hospitals, Ambulatory and Outpatient Facilities, Diagnostic Laboratories, Academic and Clinical-Research Institutions); By Geography, Segment Revenue Estimation, Forecast, 2026–2032

Skin Biopsy Devices Market: Procedure-Led Demand Is Expanding Beyond Conventional Dermatology

The Global Skin Biopsy Devices Market was valued at USD 185 million in 2025 and is projected to reach USD 295 million by 2032, expanding at a CAGR of 6.9% during 2026–2... Read More

Published Date: JUL-2026 | No Of Pages:174 | $ 4485

AI-Powered Sleep Technologies Market By Product (Wearable Sleep Trackers, Smart Adjustable Mattresses and Beds, Anti-Snoring Pillows, Contactless Sleep Monitoring Systems, AI-Powered Sleep Applications and Software), By Application (Sleep Tracking and Wellness Management, Obstructive Sleep Apnea Screening and Diagnosis, Snoring Detection and Management, Sleep-Stage Analysis, Remote Patient and Therapy Monitoring), By End User (Residential Consumers, Hospitals and Sleep Clinics, Diagnostic Centers, Wellness and Fitness Centers, Home Healthcare Providers), By Geography, Segment Revenue Estimation, Forecast, 2026–2032

AI-Powered Sleep Technologies Market: Artificial Intelligence Advances Sleep Monitoring Toward Personalized and Predictive Health Management

The Global AI-Powered Sleep Technologies Market was valued at USD 6.15 billion in 2025 and is projected to reach USD 19.13 bill... Read More

Published Date: JUL-2026 | No Of Pages:190 | $ 4485

Ataxia Market By Product/Service (Pharmaceutical Therapies, Diagnostic and Monitoring Services, Rehabilitation Services, Assistive and Communication Devices); By Application (Friedreich Ataxia, Spinocerebellar Ataxias, Other Hereditary Ataxias, Sporadic and Idiopathic Progressive Ataxias); By End User (Hospitals and Specialist Neurology Centres, Rehabilitation Centres, Diagnostic Laboratories, Specialty Pharmacies and Homecare Providers); By Geography, Segment Revenue Estimation, Forecast, 2026–2032

Ataxia Market: Supportive-Care Scale Meets the Rise of Precision Neurology

The Global Ataxia Market was valued at USD 1.05 billion in 2025 and is projected to reach USD 2.25 billion by 2032, expanding at a CAGR of... Read More

Published Date: JUL-2026 | No Of Pages:192 | $ 4485

Calcium Hydroxylapatite Fillers Market By Product Type (Pure Calcium Hydroxylapatite Fillers, Hybrid HA-CaHA Fillers); By Application (Facial Wrinkles and Folds, Jawline Contouring, Hand Rejuvenation, Décolleté Rejuvenation, Skin Laxity and Volume Restoration); By End User (Dermatology Clinics, Plastic Surgery Clinics, Medical Spas and Aesthetic Clinics, Hospitals and Outpatient Centres); By Geography, Segment Revenue Estimation, Forecast, 2026–2032

Calcium Hydroxylapatite Fillers Market: From Structural Correction to Biostimulatory Aesthetic Growth

The Global Calcium Hydroxylapatite Fillers Market was valued at USD 0.72 billion in 2025 and is projected to reach USD 1.60 billion by 2032, ... Read More

Published Date: JUL-2026 | No Of Pages:188 | $ 4485

Contraceptive Patch Market By Product (Xulane, Twirla, Zafemy, Evra, Other Branded and Investigational Contraceptive Patches), By Hormone Combination (Norelgestromin and Ethinyl Estradiol, Levonorgestrel and Ethinyl Estradiol, Other Low-Dose Estrogen–Progestin Combinations), By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online Pharmacies), By Geography, Segment Revenue Estimation, Forecast, 2026–2032

Contraceptive Patch Market: Where Weekly Dosing Convenience Meets Estrogen-Driven Clinical Limitations

The Global Contraceptive Patch Market was valued at USD 1.15 billion in 2025 and is projected to reach USD 1.80 billion by 2032, expanding at a CAGR of 6.6% during 2... Read More

Published Date: JUL-2026 | No Of Pages:160 | $ 4485

CDK4/6 Inhibitors Market By Drug (Palbociclib, Ribociclib, Abemaciclib, Next-Generation Selective CDK Inhibitors, Investigational CDK4/6 Degraders), By Indication (HR-Positive/HER2-Negative Advanced or Metastatic Breast Cancer, High-Risk Early Breast Cancer, HR-Positive/HER2-Positive Breast Cancer, Other Solid Tumours), By End User (Hospitals, Specialty Oncology Clinics, Cancer Treatment Centres, Academic and Clinical Research Institutions), By Geography, Segment Revenue Estimation, Forecast, 2026–2032

CDK4/6 Inhibitors Market: Early-Stage Expansion Redefines an Oncology Drug Class

The Global CDK4/6 Inhibitors Market was valued at USD 15.35 billion in 2025 and is projected to reach USD 25.80 billion by 2032, growing at a CAGR of 7.7% (2026–2032)... Read More

Published Date: JUL-2026 | No Of Pages:190 | $ 4485

Next-Generation Immune Checkpoint Inhibitors Market By Target (LAG-3, TIGIT, TIM-3, VISTA, B7-H3, NKG2A, CD73, Other Emerging Immune Checkpoints), By Therapeutic Modality (Monoclonal Antibodies, Fixed-Dose Combination Antibodies, Bispecific Antibodies, Tumor-Activated Immune Modulators, Antibody-Drug Conjugates), By Application (Melanoma, Non-Small Cell Lung Cancer, Gastric and Esophageal Cancer, Hematologic Malignancies, Colorectal Cancer, Ovarian Cancer, Head and Neck Cancer, Other Solid Tumors), By End User (Hospitals and Cancer Centers, Specialty Oncology Clinics, Academic and Clinical Research Institutions), By Geography, Segment Revenue Estimation, Forecast, 2026–2032

Next-Generation Immune Checkpoint Inhibitors Market: From Target Discovery to Evidence-Driven Combination Immunotherapy

The Global Next-Generation Immune Checkpoint Inhibitors Market was valued at USD 1.19 billion in 2025 and is projected to reach USD 4.65 billion by ... Read More

Published Date: JUL-2026 | No Of Pages:180 | $ 4485